CHOWIS Leverages the Power of AI to Revolutionize Beauty and Cosmetic Market

With the advent of AI and Big Data in the rapidly expanding beauty tech market, Korea-based personal care product manufacturing company CHOWIS Co., leveraging the power of artificial intelligence (AI) to revolutionize the beauty and cosmetic market, is quickly gaining traction globally.

CHOWIS's popularity is increasing as the demand for personalized care products that cater to consumers' unique needs, such as specific skin types, using AI grows.

CHOWIS is a diagnostic and evaluation technology company specializing in optics, video image processing technology, and software development. Since its inception in 2012, the company's unique AI algorithm analysis solutions based on big data have added to its reputation. 

The personal care product manufacturing company has worked successfully with global majors in the cosmetics industry, such as L'Oreal in France, P&G Group in Japan, Nivea in Germany, and AmorePacific in Korea.

With the support of the Korean government and Gyeonggi Province, CHOWIS has been assisting in the growth of personal care product manufacturing since 2021 by providing customized AI-based healthcare service test beds and a PoC (Proof of Concept).

The company accomplished this feat by installing two unmanned kiosks, dubbed "mySkin KIOSK" and "myHair KIOSK." The kiosks use AI to diagnose visitors' skin and hair and then provide them with customized digital beauty and health solutions based on the results. This aligns well with the growing popularity of non-face-to-face services around the world.

CHOWIS recently entered the U.S. market by collaborating with a local partner and entering leading global retail stores. Based on scalp & hair analysis results obtained from the kiosks, the customers get personalized cosmetic products.

CHOWIS has launched PRECISION SKIN DermConcept, an AI-based home skin diagnosis and personalized cosmetics platform service in the United Kingdom. By tracking skin conditions via an application, this service provides information for doctors and pharmacists to prescribe new cosmetics to users every month. 

The skin condition analyses performed by CHOWIS's "DPI Viso" diagnostic devices are updated in real-time. CHOWIS's "DPI Viso" device was shipped as part of a starter kit for new members by DermConcept, and 100 have already been delivered.

In addition, CHOWIS is working on a small personal device called mySkin F.A.I.N (Face AI Navigator). It will allow consumers to analyze their skin using AI anytime and anywhere. CHOWIS hopes to launch this in the second half of 2022.

Ryan Choi, CEO of CHOWIS, said, "AI as a technology is critical for improving competitiveness in the global beauty market. Since its inception in 2012, CHOWIS has developed innovative products that use cutting-edge technologies, gaining experience through collaborations with global corporations. CHOWIS will continue to lead the future beauty tech and digital health markets by expanding partnerships with companies from a wider range of countries."


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.